Scancell Limited

 Scancell Limited contact information is shown below
Owner:SCANCELL LIMITED
Owner Address:Unit 202, Bellhouse Building Sanders Road, Oxford Science Park Oxford OX44GD United Kingdom
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byScancell Limited

Brand:

AVIDIMAB

Description:

Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; compounds for the treatment of cancer;

Category: PHARMACEUTICAL
Brand:

GLYMAB

Description:

Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; compounds for the treatment of cancer;

Category: PHARMACEUTICAL
Brand:

IMMUNOBODY

Description:

Therapeutic preparations and substances for medical use, namely, DNA, antibodies and proteins for use in expressing epitopes, for use in encoding, for use in vectoring to target cells, and for use in stimulating cells; vaccines, including DNA vaccines;

Category: THERAPEUTIC PREPARATIONS SUBSTANCES
Brand:

IMMUNOBODY

Description:

Therapeutic preparations and substances for medical use, namely, DNA, antibodies and proteins for use in expressing epitopes, for use in encoding, for use in vectoring to target cells, and for use in stimulating cells; vaccines, including DNA vaccines;IMMUNO BODY;

Category: THERAPEUTIC PREPARATIONS SUBSTANCES
Brand:

SCANCELL

Description:

Pharmaceutical preparations, namely, for the treatment of cancer; therapeutic preparations and substances, namely, for the treatment of cancer; chemical preparations, namely, for the treatment of cancer; diagnostic reagents for medical use; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances; Therapeutic preparations and substances for medical use, namely, DNA, antibodies and proteins for use in expressing epitopes, for use in encoding, for use in vectoring to target cells, and for use in stimulating cells; vaccines, including DNA vaccines; Therapeutic preparations for use in T-cell therapy and chimeric antigen receptor T-cell therapy to treat cancer;Pharmaceutical testing and clinical trials for others; provision of information and consultancy in relation to the aforesaid services; scientific and technological services, namely, research and design in the field of drug development for the treatment of cancer; pharmaceutical research and development services; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services;

Category: PHARMACEUTICAL PREPARATIONS